In yesterday’s column, Wilmer’s Bill Lee and trial consultant Jamie Laird identified what they see as the problem: There’s been a marked increase in the number of $10 million-plus damages awards against corporate defendants in the wake of the pandemic. There’s also been a spike in the total value of those awards—verdicts which many have dubbed “nuclear” but that Lee and Laird call “outsized.” 

Regardless of what they’re called, what should lawyers do to address them?

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]